Insulin pumps tied to over 2,000 injuries recalled | Pharmafile
Pertinent Data for Patients and Their Conventional Insulin Pump at Baseline | Download Table
Novo Nordisk introduces NovoRapid PumpCart insulin pump
Health Canada approves fast-acting mealtime insulin, Fiasp®, for children with diabetes
Insulin Pump Therapy for Type 2 Diabetes | Medtronic Diabetes
Medtronic and Novo Nordisk announce major diabetes collaboration - Diabetes
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial - The Lancet
Novo Nordisk's Fiasp (insulin aspart injection) Receives the FDA's Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes | PharmaShots
Evidence for Type 2s to go on insulin pumps
NOVO NORDISK: FDA approves Fiasp® for use in insulin infusion pumps for adults with type 1 or type 2 diabetes | FDA Health News
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial - The Lancet Diabetes & Endocrinology
Novo's New Faster-Acting Insulin FIASP | DiabetesMine
Diabetes Devices Market: Increase in Adoption of Insulin Pump among Type 1 Diabetes Patients Boost Market Growth | Medgadget
The Latest and Greatest in Insulin Pumps and Sensor Technology - Taking Control Of Your Diabetes
Insulin Pump Therapy for Type 2 Diabetes | Medtronic Diabetes
NovoLog® Insulin Pen Options | NovoLog® (insulin aspart injection) 100 U/mL
Surge in FDA Approvals for Diabetes Devices and Product Advances
Insulin Pump Therapy for Type 2 Diabetes | Medtronic Diabetes
FDA approves Fiasp in insulin infusion pumps for adults — Juicebox Podcast and Arden's Day
Insulin Pump Therapy for Type 2 Diabetes | Medtronic Diabetes
Insulin 100 years
Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis - Kidney International
Fiasp® Onset of Appearance | Fiasp® (insulin aspart injection) 100 U/mL
Novo Nordisk and Roche' insulin pump system gets EU thumbs up
FDA OKs Novo Nordisk's Fiasp for infusion pumps - MassDevice
